MetLife Investment Management, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,976,834
+56.1%
21,2700.0%0.02%
+41.7%
Q3 2021$1,266,629
-19.0%
21,270
-7.2%
0.01%
-20.0%
Q2 2021$1,563,076
-1.7%
22,9190.0%0.02%0.0%
Q1 2021$1,590,349
-9.7%
22,9190.0%0.02%
-16.7%
Q4 2020$1,760,867
-3.6%
22,919
-6.1%
0.02%
-10.0%
Q3 2020$1,825,923
+18.8%
24,4140.0%0.02%
+17.6%
Q2 2020$1,536,861
+75.1%
24,414
+16.8%
0.02%
+41.7%
Q1 2020$877,842
-14.1%
20,901
-7.1%
0.01%
+9.1%
Q4 2019$1,021,496
-0.8%
22,4900.0%0.01%
-8.3%
Q3 2019$1,029,367
-21.9%
22,4900.0%0.01%
-20.0%
Q2 2019$1,318,589
+30.8%
22,4900.0%0.02%
+36.4%
Q1 2019$1,008,227
+15.1%
22,4900.0%0.01%0.0%
Q4 2018$875,986
-15.4%
22,4900.0%0.01%0.0%
Q3 2018$1,034,990
+5.5%
22,4900.0%0.01%
-8.3%
Q2 2018$981,000
+10.5%
22,4900.0%0.01%
+20.0%
Q1 2018$888,000
+39.8%
22,490
+20.3%
0.01%
+42.9%
Q4 2017$635,00018,6910.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders